Wenjie Tan to Antibodies, Viral
This is a "connection" page, showing publications Wenjie Tan has written about Antibodies, Viral.
Connection Strength
0.922
-
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections. EBioMedicine. 2020 Aug; 58:102890.
Score: 0.085
-
Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates. Vaccine. 2019 04 03; 37(15):2122-2130.
Score: 0.077
-
Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus. Virol Sin. 2018 Oct; 33(5):453-455.
Score: 0.075
-
Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient. J Infect Dis. 2018 09 08; 218(8):1249-1260.
Score: 0.074
-
A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice. Sci China Life Sci. 2018 Oct; 61(10):1280-1282.
Score: 0.074
-
A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg Microbes Infect. 2017 May 24; 6(5):e37.
Score: 0.068
-
Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China. Emerg Microbes Infect. 2016 Nov 09; 5(11):e113.
Score: 0.066
-
The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. Viral Immunol. 2014 Dec; 27(10):543-50.
Score: 0.057
-
[Antigenicity characterization of six different fragments of SARS-CoV N protein expressed in E. coli]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012 Feb; 26(1):40-2.
Score: 0.047
-
[Expression and purification of different segments from HCoV-NL63 nucleocapsid protein and their application in detection of antibodies]. Bing Du Xue Bao. 2011 May; 27(3):244-9.
Score: 0.045
-
SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients. Cell Mol Immunol. 2021 08; 18(8):2040-2041.
Score: 0.023
-
Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study. Virol Sin. 2021 10; 36(5):1088-1092.
Score: 0.023
-
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity. Signal Transduct Target Ther. 2021 05 31; 6(1):213.
Score: 0.022
-
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice. Cell Mol Immunol. 2021 03; 18(3):749-751.
Score: 0.022
-
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020 06 12; 368(6496):1274-1278.
Score: 0.021
-
Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein. Nat Commun. 2019 07 11; 10(1):3068.
Score: 0.020
-
Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect. 2018 Apr 04; 7(1):60.
Score: 0.018
-
[Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice]. Bing Du Xue Bao. 2016 Jan; 32(1):77-81.
Score: 0.015
-
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge. EBioMedicine. 2015 Oct; 2(10):1438-46.
Score: 0.015
-
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology. 2015 Aug; 145(4):476-84.
Score: 0.015
-
First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood. BMC Infect Dis. 2013 Sep 16; 13:433.
Score: 0.013
-
[Consecutive five-year follow-up analysis of specific IgG antibody of 22 cases of SARS patients after recovery]. Bing Du Xue Bao. 2010 Jul; 26(4):295-7.
Score: 0.011
-
SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice. Viral Immunol. 2009 Feb; 22(1):57-66.
Score: 0.010
-
[Development and application of a safe SARS-CoV neutralization assay based on lentiviral vectors pseudotyped with SARS-CoV spike protein]. Bing Du Xue Bao. 2007 Nov; 23(6):440-6.
Score: 0.009
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
Score: 0.005
-
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
Score: 0.005
-
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020 05 29; 368(6494):1016-1020.
Score: 0.005
-
[Development of serological detection assays for human coronavirus HKU1 infection and its application]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Oct; 24(5):376-9.
Score: 0.003